IBD Activity May Increase Risk for Clostridioides Difficile Infection
By Elana Gotkine HealthDay Reporter
WEDNESDAY, March 5, 2025 -- For patients with inflammatory bowel disease (IBD), risk factors associated with Clostridioides difficile infection (CDI) include recent diagnosis, corticosteroid usage, and hospitalization, according to a study published online Feb. 17 in Therapeutic Advances in Gastroenterology.
Krista Vitikainen, from Helsinki University Hospital, and colleagues conducted a case-control cohort study of patients with IBD with and without CDI episodes to examine clinical risk factors for CDI and its recurrence. The study included 279 patients with IBD and CDI. Medical history and IBD-related symptoms three months preceding a toxin-positive CDI were recorded and compared to patients with IBD who did not have CDI (matched for sex and age).
The researchers found that IBD was active before CDI based on clinical symptoms and fecal calprotectin levels. The risk for CDI was increased with recently diagnosed IBD. CDI episodes were frequently preceded by corticosteroid usage (64 percent). There was no association seen for advanced therapies with CDI. In 30 percent of the episodes, antibiotic intake was not registered before CDI. Thirty percent of the patients with IBD and CDI were hospitalized before the primary CDI. Recurrent CDI occurred in 30 percent of patients with IBD and CDI; two-thirds of these episodes were registered within 90 days of the previous episode. Overall, 79 percent of patients with recurrent CDI had ulcerative colitis.
"The prior use of corticosteroids, hospitalization, and the presence of gastrointestinal symptoms before CDI likely indicate an underlying IBD flare, suggesting that inadequate disease control may contribute to the risk of CDI," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
Spatiotemporal Mapping IDs Four Stages of Inflammatory Bowel Disease Evolution
TUESDAY, May 6, 2025 -- Machine learning has enabled spatiotemporal mapping of the four stages of the evolution of inflammatory bowel disease (IBD), according to a study published...
Gastrointestinal Disease Tied to High Physical, Financial Burden
FRIDAY, April 18, 2025 -- Gastrointestinal (GI) diseases are responsible for a considerable and growing burden of health care use and costs within the United States, according to...
Environmental Surfaces, Clinician Hands Play Role in C. Difficile Transmission in ICU
THURSDAY, April 10, 2025 -- Environmental surfaces and health care personnel (HCP) hands play an important role in Clostridioides difficile transmission within health care...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.